NorthWest Biotherapeutics Inc (NWBO)

[antihama]

Assuming DCVax-L is successful than I would object if NWBO is not valued appropriately if they ever considered a merger. It may or may not take a little time for that to happen. And even if NWBO was valued appropriately where the market knows it has a paradigm shifting drug I would still think it's a bad idea because Alzheimer's is not in NWBO's wheelhouse. NWBO would need to focus on most solid tumors out there both operable (DCVax-L) and inoperable (Direct). They need to be totally focused on that. I think it's a totally bad idea and the most likely outcome would be that NWBO investors would be robbed of a great opportunity; that's assuming the DCVax-L trial is successful. I just had to put my 2 cents out there.